Ecovativa Design is a private company building in biotechnology / materials, founded in 2007. Investors last valued the company at $130M. The stock is not listed on any public market.
One company valuation: $130M, dated Dec 2025.
Viking Global InvestorsLEADSStandard InvestmentsFFootPrint Coalition VenturesAAiiM PartnersEcovative Design grows mycelium-based materials that replace plastic and polystyrene foam in packaging, building insulation and other products, alongside farmed mycelium proteins meant to reduce reliance on animal agriculture. Its MycoComposite platform underlies protective packaging once used by Dell, Puma and Steelcase. Founders Eben Bayer and Gavin McIntyre developed the growing method at Rensselaer Polytechnic Institute and founded the company in Green Island, New York, in 2007.
IKEA committed in February 2020 to replacing polystyrene packaging with Ecovative's technology, and in 2014 the company built mycelium bricks into Hy-Fi, a 40-foot tower displayed by the Museum of Modern Art in New York.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Ecovativa Design.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Ecovativa Design availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Ecovativa Design included.
No. Ecovativa Design is a private company; its shares do not trade on a public exchange.
The last valuation is $130M.
Lead investors for each round are in the funding timeline.
The closest biotechnology / materials peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
